Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
European Journal of Clinical Pharmacology|November 25, 2006
Contraindication labelling changes in the United States and GermanyEdeltraut Garbe, Frank Andersohn
Movement Disorders : Official Journal of the Movement Disorder Society|January 27, 2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonistsFrank Andersohn, Edeltraut Garbe
Pharmacoepidemiology and Drug Safety|July 24, 2012
Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS)Niklas Schmedt, Frank Andersohn, Edeltraut Garbe
Inflammatory Bowel Diseases|December 17, 2009
Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control studyFrank Andersohn, Mark Waring, Edeltraut Garbe
Annals of Internal Medicine|May 2, 2007
Systematic review: agranulocytosis induced by nonchemotherapy drugsFrank Andersohn, Christine Konzen, Edeltraut Garbe
Circulation|April 19, 2006
Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarctionFrank Andersohn, Samy Suissa, Edeltraut Garbe
Pharmacoepidemiology and Drug Safety|June 29, 2010
Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German databaseSigrid Behr, Frank Andersohn, Edeltraut Garbe
Stroke|May 27, 2006
Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control studyFrank Andersohn, René Schade, Samy Suissa, et al.
Diabetes, Obesity & Metabolism|July 27, 2018
Sodium-glucose co-transporter-2 inhibitors and the risk of fractures of the upper or lower limbs in patients with type 2 diabetes: A nested case-control studyNiklas Schmedt, Frank Andersohn, Jochen Walker, et al.
American Journal of Hematology|October 21, 2004
Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance StudyFrank Andersohn, Elisabeth Bronder, Andreas Klimpel, et al.
Pageof 14